Navigation Links
National Jewish Health receives patent for diagnostic method of autoimmune chronic urticaria
Date:11/1/2010

National Jewish Health has received a US patent for a method of detecting autoimmune chronic urticaria, which will help assure many patients that dramatic changes in lifestyle are not needed to treat the condition. Ronald Harbeck, PhD, Medical Director of the Advanced Diagnostic Laboratories at National Jewish Health, and colleagues Drs. Karen Andrews and Donald MacGlashan, Jr. developed the diagnostic assay, which makes use of the protein CD203c as a marker for the condition. The test, offered by the diagnostic laboratories at National Jewish Health, has been highly successful, with 250 to 300 tests run every week for patients around the nation.

Chronic urticaria is recurrent hives that last for six weeks or longer. They can be caused by allergic and non-allergic reactions. It is often difficult to pin down a specific cause. Without a known cause, many patients will try various adjustments to their lifestyles in an often unsuccessful attempt to cure the hives.

"Patients will often try eliminating foods from their diet or pets from their homes and alter their medications, believing they are suffering from allergic reactions," said Dr. Harbeck.

Approximately 40 percent of chronic urticaria patients have an autoimmune form of the disease, which is essentially a malfunction of the immune system and has no external cause. Doctors can prescribe a variety of treatments for chronic urticaria, based on symptoms, but rarely prescribe a significant change in lifestyle. The recently granted patent describes a method for detecting this autoimmune form of chronic urticaria.

"This diagnostic method will allow some patients to continue their normal, daily lives knowing that they are not suffering from an allergic condition," said Dr. Harbeck.

The invented method includes detecting the expression of the protein CD203c on cells in the presence of the antibody present in chronic urticaria patients.

"The creation of this diagnostic test is a reflection of the quality of research performed by our scientists and the commitment from National Jewish Health to support the advancement of research discoveries towards clinical applications in the spirit of our brand promise, Science Transforming Life," said Emmanuel Hilaire, PhD, Manager of the Technology Transfer Office at National Jewish Health.


'/>"/>

Contact: William Allstetter
allstetterw@njhealth.org
303-398-1002
National Jewish Health
Source:Eurekalert

Related medicine news :

1. NationalCreditReport.com Reminds Consumers of Ways to Improve Credit Report and Score in 2010
2. The National Coalition for Cancer Survivorship Joins the Commission on Cancer
3. National Wildlife Federation Says Outdoor Time for Kids Can Help First Lady Achieve Her “Let's Move” Goal
4. Howard Dean to Speak at the 2010 DTC National Conference
5. International Diabetes Federation awards $2 million to 9 global diabetes research projects
6. Jion Beijing Great Wall International Travel Agency Immediate Exposure to China Expo 2010
7. U.S. National Guard Connects Nationwide with Desktop Alert's Command and Control Mass Notification Systems and Common Alerting Protocol (CAP)
8. H1N1 international symposium to be hosted by Emory-UGA Influenza Center
9. The Alliance for a Healthier Generation Names Celtics Captain Paul Pierce National Athlete Spokesperson in the Fight Against Childhood Obesity
10. Researchers Who Discovered First Genes for Stuttering will Present Findings to the National Stuttering Association
11. Protecting patients: Study shows that Johns Hopkins flu vaccination rates twice national average
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... "With 30 hand-drawn ... specific project," said Christina Austin - CEO of Pixel Film Studios. , ProHand ... all within Final Cut Pro X . Simply select a ProHand generator and ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 24, 2016   Bay Area Lyme Foundation ... Dean Center for Tick Borne Illness , Harvard ... MIT Hacking Medicine, University of California, Berkeley, and ... the five finalists of Lyme Innovation , ... than 100 scientists, clinicians, researchers, entrepreneurs, and investors ...
(Date:6/24/2016)... SAN CLEMENTE, Calif. , June 24, 2016  American Respiratory ... testing company, is now able to perform sophisticated lung assessments in ... Medical Technologies , Inc. Patients are no longer ... to ndd,s EasyOne PRO ® , ARL patients like Jeanne R. ... testing done in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
Breaking Medicine Technology: